Impact of Smoking on Pancreatic Cancer Patients Receiving Current Chemotherapy.

• 資料種別: 博士論文
• タイトル: Impact of Smoking on Pancreatic Cancer Patients Receiving Current Chemotherapy.
• 著者・編者: Kawaguchi, Chihiro; Sho, Masayuki; Tanaka, Toshihiro; Akahori, Takahiro; Kinoshita, Shoichi; Nagai, Minako; Yasuda, Satoshi; Nishiwada, Satoshi; Nishiofuku, Hideyuki; Kichikawa, Kimihiko; Nakajima, Yoshiyuki
• 著者標目: Kawaguchi, Chihiro; Sho, Masayuki; Tanaka, Toshihiro; Akahori, Takahiro; Kinoshita, Shoichi; Nagai, Minako; Yasuda, Satoshi; Nishiwada, Satoshi; Nishiofuku, Hideyuki; Kichikawa, Kimihiko; Nakajima, Yoshiyuki
• 出版事項: Wolters Kluwer Health, Inc.
• 出版年月日等: 2015-10
• 出版年（W3CDTF）: 2015-10
• 並列タイトル等: 化学療法を施行した膵癌患者に対する喫煙の影響
• タイトル（掲載誌）: Pancreas
• 巻号年月日等（掲載誌）: 44 7
• 掲載巻: 44
• 掲載号: 7
• 掲載ページ: 1155-1160
• ISSN（掲載誌）: ISSN : 0885-3177
• 授与機関名: 奈良県立医科大学
• 授与年月日: 2017-03-15
• 報告番号: 乙第1393号
• 学位: 博士（医学）
• 本文の言語コード: eng
• 件名標目: chemotherapy; pancreatic cancer; prognosis; smoking; surgery
• 対象利用者: 一般
• 一般注記: type:Thesis; OBJECTIVE: Smoking may affect pharmacokinetics of chemotherapeutic agents and hemodynamics of the smokers, thereby influencing adverse events and efficacy of chemotherapy in patients with pancreatic cancer (PC). The aim of this study was to clarify how smoking totally affected patients with PC receiving current chemotherapy. METHODS: We evaluated the impact of smoking status on the performance of chemotherapy and survival in 262 patients with PC including 158 resectable and 104 unresectable PC. RESULTS: There were more male and younger patients in current smokers than in nonsmokers. In unresectable PC, current smokers had more metastatic tumors than locally advanced tumors compared with nonsmokers. In current smokers receiving chemotherapy, the baseline white blood cell count, neutrophil count, and hemoglobin concentration were significantly higher in current smokers than in nonsmokers. Furthermore, grades 3 to 4 neutropenia was observed more often in nonsmokers than smokers. On the other hand, the performance and efficacy of the planned adjuvant chemotherapy were similar between smokers and nonsmokers. More importantly, there was no significant difference in overall prognosis between smokers and nonsmokers receiving chemotherapy. CONCLUSIONS: Smoking status has no significant impact on the efficacy of current chemotherapy for both resectable and unresectable PC.; 博士（医学）・乙第1393号・平成29年3月15日; Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.; This is a non-final version of an article published in final form in "http://dx.doi.org/10.1097/MPA.0000000000000395"; identifier:Pancreas Vol.44 No.7 p.1155-1160 (2015 Oct); identifier:08853177; identifier:http://ginmu.naramed-u.ac.jp/dspace/handle/10564/3326; identifier:Pancreas, 44(7): 1155-1160
• オンライン閲覧公開範囲: インターネット公開
• 関連情報（DOI）: 10.1097/MPA.0000000000000395
• 連携機関・データベース: 国立情報学研究所 : 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）; https://irdb.nii.ac.jp
• 提供元機関・データベース: 奈良県立医科大学 : 奈良県立医科大学機関リポジトリ GINMU

目次

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/3326/1/01_%e4%b9%991393%e6%9c%ac%e6%96%87%e3%81%ae%e8%a6%81%e6%97%a8.pdf fulltext

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/3326/2/02_%e4%b9%991393%e5%af%a9%e6%9f%bb%e8%a6%81%e6%97%a8.pdf fulltext

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/3326/3/03_%e4%b9%991393%e6%9c%ac%e6%96%87.pdf fulltext